Post ShowReport 2014

2-4 December 2014Bombay Convention & Exhibition Centre Mumbai, India

A UBM Event

Co-located events:

2 3

THANK YOU PARTNERS CONTENT

4 | Show Profile

5 | Show Feature

6-9 | Overview

10-15 | Facts & Figures

16 | Exhibitor Testimonials

17 | Visitor Testimonials

18-19 | Glimpses

20 | Print Media Coverage

21 | Online Media Coverage

22 | Free Marketing

23 | Networking & Learning

4 5

CPhI & P-MEC India 2014 is the epitome of India’s strength in the Pharma industry. This show has consistently grown to serve as an exclusive congregation for key players and professionals across the pharmaceutical sector. The ideal platform to network, exhibit, share, and ideate CPhI & P-MEC India has led to the growth of businesses and the industry at large.

Spread over 55,000 sqm in eight exhibi-tion halls of Bombay Convention & Ex-hibition Centre, Mumbai, this three-day mega event delighted the Pharma world with the latest solutions and technol-ogies presented by its 1087 exhibitors from 25 countries. CPhI & P-MEC India 2014 attracted 32,631 attendees from 97 countries across the globe.

SHOW PROFILE

CPhI India remains South Asia’s leading pharmaceuti-cal ingredients event. With exhibitors from all corners of the world, the event will pro-vide you with unrivalled ac-cess to the fastest growing emerging market and ex-plore unique opportunities.

BioPh India offers a natu-ral business platform to the world of pharma, focusing on biopharmaceutical de-velopment and services, both face to face and online.

P-MEC India delivers South Asia’s finest innovative pharmaceutical machinery, equipment and technology to a worldwide forum of de-cision makers through face to face networking.

ICSE India connects the global pharmaceutical com-munity with outsourcing solution providers from In-dia and abroad, offering a forum for business develop-ment and networking.

SHOW FEATURES

Launch of India Pharma Market report by UBM & Global Business Reports

The celebration of innovation at India Pharma Awards 2014

CPhI India Technical Seminar on industry trends & challenges

The three day premier event that showcases India’s

strength in the Pharma industry

1087exhibitors

from25 countries

32,631attendees

from

97countries

4 Events under one roof

6 7

(IPA); Ramesh Swaminathan. Chief Financial Officer, Lupin Pharma; and Kewal Handa, Founder Chairman, Salus Lifecare, the discussion provided new insights to the strategy tool kit of pharma industry professionals.

Reliance Commercial Finance was the event’s Presenting Partner for the 2014 edition of India Pharma Awards. The gold partner for the event was the prestigious UK Trade & Investment (UKTI). Other partners included Airline Partner- Qatar Airways, Category Partner- International Biotech Park, Knowledge Partner – Express Pharma, Official Partner – Microsoft mobile devices & services and Gifting Partner - Giftxoxo.com

CPhI Pharma Insights: India 2015 report

A printed report – entitled: ‘CPhI India Pharmaceuticals 2015 - Industry explorations’ was released during the CPhI/ P-MEC India 2014–in partnership with GBR. The report provides a comprehensive analysis

others participating. With over 32,000 delegates from across the globe attending the event, the show provided the perfect platform for India to move up the Global Pharma value chain.

P-MEC India, co-located with CPhI India and in its 8th year, provides the industry with an

2nd India Pharma Awards, 20141st December 2014, Westin Garden City, Mumbai

The India Pharma Awards initiated by UBM India celebrate the thinkers and creators who consistently break new ground in the pharma sector thereby taking the value chain to its next level. These awards honour innovation and excellence in the Indian pharmaceutical industry, thus creating an industry platform to celebrate the contribution of its key players amongst their Indian and international fraternity. Winners were declared across 9 categories with over 100 companies participating in this year’s awards.

The process advisor to the prestigious event was Ernst & Young, while other jury members consisted of distinguished and renowned industry stalwarts such as Dr. Ajit Dangi, President & CEO-Danssen Consulting; Dr. Safia Rizvi, Managing Director-UCB India Private Ltd; Devinder Pal, President-Catalyst Pharma Consulting and S V Veerramani, Founder & Chairman-Fourrts (India) Laboratories Pvt. Ltd. & President-IDMA.

• Over32,000 industryexecutivesfrom 100+ countries attend the event

• CPhIIndiaTechnicalSeminaronindustry trends & challenges

• Innovation sweeps 2nd AnnualIndia Pharma Awards 2014

• Launch of India Pharma Marketreport by UBM & Global Business Reports

Mumbai, December, 2014 – UBM India’s largest business event catering to the Indian Pharmaceutical industry, CPhI/ P-MEC India 2014 successfully concluded on the 4th of December 2014 in Mumbai. Touted as one of the biggest Pharma event in Asia, this is a platform wherein key players of the pharmaceutical sector, worldwide, congregate to connect, share and ideate.

Spread over three days the event which is co-located with P-MEC India, ICSE India & BioPh witnessed participation of 1087 exhibitors from over 95 countries representing China, Turkey, Japan, United Kingdom and USA among

INDIA INC. AIMS FOR PHARMA DOMINANCE BY 2020

international platform to showcase pharmaceutical equipment, machinery and technology to a forum of decision makers from across the world. Additionally, ICSE India has rapidly gained a positive

reputation in the market by offering direct access to the outsourcing and contract services sector which is one of the fastest growing segments within the Indian pharmaceutical industry.

Joji George, Managing Director, UBM India said, “Against the backdrop of India constantly seeking to match and surpass western quality standards while maintaining lower manufacturing costs, at UBM, our objective for CPhI 2014 is to help elevate India as the global pharmaceutical destination by showcasing the unique positioning of the Indian pharma market and provide an optimum investment platform amidst its global counterparts.”

OVERVIEW OVERVIEW

The Awards ceremony was preceded by a panel discussion, titled: FROM VOLUMES TO VALUE PLAY: TOWARDS ACHIEVING VISION

2020. Panelists deliberated on the factors holding back the Indian pharma industry, from transitioning from volumes to a value play and also gave their recommended strategies for success. With panelists like Dr Ajit Dangi, President and CEO, Danssen Consulting; D G Shah, Secretary General, Indian Pharmaceutical Alliance

Category Winners

Operational Excellence - API Dr. Reddy’s Laboratories Ltd.

Operational Excellence - Formulation Zydus Cadila Healthcare Ltd.

Excellence in Environment, Jubilant Lifesciences Ltd. Health & Safety (EHS)

Excellence in Packaging Development ACG Worldwide

Excellence in Contract Research Akums Drugs & Pharmaceuticals Ltd.

Excellence in Corporate Social 1) Piramal Foundation Responsibility 2) Jubilant Life sciences Ltd.

Emerging Entrepreneur of the Year Ranjeeta Vinil (Saarathi Healthcare Pvt. Ltd.)

Lifetime Achievement Award Mr. Ajit Singh ( ACG Worldwide)

Special Jury Award Dr. J N Banerjee

8 9

of the India pharma market. Overall the report shows that despite moderate growth in last few years, Indian companies seemed to be showing strong sense of growth and positive market sentiments in near future. Indian pharma is pitting itself to be among the top players by the year 2020. Most companies from India involved in outsourcing and exports sector are already showing promising growth as per the report.CPhI has been a key presence in India for a number of years and the event is an essential cog in internationalising this pharma hub. What’s been most impressive is the ability of companies in India to constantly develop themselves through new services and technologies. These findings and trends clearly show India is cementing itself as the global centre of generics and manufacturing innovations. Over the next few years, many of the companies present at CPhI India 2014, will grow into global entities supplying both western and developing markets.

Report highlights:

• CPhI India report forecastsnewMNCs to emerge from India’s pharma SMEs and Japan & Africa as key export growth markets

• Indian manufacturers evolvingup value chain, concentrating on high-value, low volume work and shifting some R&D programmes to Western economies. NCE launch predicted in next few years

OVERVIEW OVERVIEW

• India’s biggest companies willsee growth in CRAMS services for patented products as trust in regulatory and quality standards increases

o India to increasing become a hotbed of clinical trial supply and advanced development work

• Biggest players to growtechnology base through overseas acquisitions and partnering with big pharma for R&D

• Expenditures on R&D by thirtyof the top pharmaceutical companies in India rose by 19.7%, with investments focused on novel drug delivery systems

o Some of India’s biggest players are actively investing in R&D facilities abroad- Sun, Piramal, Lupin and Cipla

• NewChemicalEntitiesfromIndiato emerge in the next few years cutting edge research underway, including innovations in creating an oral dosage form of insulin

• Huge future growth potential inJapan where Indian companies currently have limited presence, but there is predicted to be a rapidly rising use of generics

• In 2015 a significant numberIndian companies will enter the African market as growth is predicted at 25% to 30% by volume per year

• Biologics and biosimilars torepresent 15% of Indian market value by 2020

• India’s API producers haveincreasingly started to shift towards high value low volume work with complex chemistry and IP challenges

CPhI/P-MEC 2014: Industry Reactions:

Sudhanshu Pandey, Joint Secretary, Dept. of Commerce, Govt. of India, “Its platform like these that recognizes people and motivates them to do better while continuing to inspire others. Last few years have been tough on the pharma sector due to various issues and challenges with regards to regulatory norms. But we must address these challenges in the right spirit. It’s a long way for Indian pharma industry, but we are on the right track. India today boasts of world class facilities. The road maybe tough but we have what it

takes to get there.”Speaking on the occasion member of the Jury Committee and an esteemed member of the Pharma fraternity Dr. Sudarshan Jain, Managing Director, Abbott Healthcare Solutions said, “TheIndian pharmaceutical sector is clearly growing, making significant contributions to the Indian economy and putting us on the global map. This sector is redefining itself by moving to ‘next practices’ from

‘best practices’. We see strong thrust in the manufacturing arena in line with our national priority of ‘Make in India’. Some of the entries for the award clearly reflect good work done by the sector and augurs well for the industry”.

Devinder Pal, President, Catalyst Pharma Consult: “One of the key challenges faced by the industry is to reclaim the enviable reputation it had earned, which has unfortunately gottarnished...ratherbadly.Happily,the FDA administered jolts have done the trick – it has awakened the industry to the need of building quality culture and shunning complacency and Juggad.”

Dr. Ajit Dangi, President & CEO , Danssen Consulting: ‘In CPhI / P- MEC , the key elements have always been innovation and excellence. Organisations are increasingly focusing on 3 Ps - People, Planet and Profit and have started recruiting Chief Sustainability Officers to give them competitive edge. The CPHi/ P-Mec event will provide good insight in to initiatives in this area.”

10 11

9%9%

1%

19%

30%

14%

18%

Africa

Asia pacific

Europe

Middle East

North America

Oceania

South / Central America

Manager / Project Manager / Department Head

CEO / Vice President / Director / GM

Sales / Marketing Manager

Purchasing / Procurement Manager

Business Development Manager

Other

Manager / Project Manager / Department Head

CEO / Vice President / Director / GM

Sales / Marketing Manager

Purchasing / Procurement Manager

Business Development Manager

Other

East

West

North

South

11%

0%

6%

83%

33%

27%

14%

7%

8%

11%

International Visitors Visitor Job Positions at CPhI

Domestic Visitors - Region Wise Visitor Job Positions at PMEC

36%

30%

6%11%

10%

7%

FACTS & FIGURES FACTS & FIGURES

12 13

MAINTAIN CONTACTS WITH EXISTING SUPPLIERS

BE UPDATED ON THE LATEST TRENDS, NEW IDEAS AND TECHNOL-OGIES

MAKE A PURCHASE

LOOK FOR NEW SUPPLIERS

TO ENTER NEW MARKETS, ATTEND SEMINARS, LOOK FOR NEW PART-NERSHIPS

TO EVALUATE EXHIBITING IN THE FUTURE

LOOK FOR NEW PRODUCTS

MAINTAIN CONTACTS WITH EXISTING SUPPLIERS

BE UPDATED ON THE LATEST TRENDS, NEW IDEAS AND TECHNOL-OGIES

MAKE A PURCHASE

LOOK FOR NEW SUPPLIERS

TO ENTER NEW MARKETS, ATTEND SEMINARS, LOOK FOR NEW PART-NERSHIPS

TO EVALUATE EXHIBITING IN THE FUTURE

LOOK FOR NEW PRODUCTS

45%

20%

6%

14%

5%9%

1%

CPhI: Visitor’s primary purpose of attending Analysis by product categories

PMEC: Visitor’s primary purpose of attending Overall Rating

49%

15%

7%

16%

5%7%

1%

FACTS & FIGURES FACTS & FIGURES

Excellent

Good

Average

Poor

51%

39%

8%

2%

43%

18%

8%

7%

5%

6%

5%

5%

1%

2%

APIS

CUSTOM MANUFACTURING

INTERMEDIATES

FINE CHEMICALS

EXCIPIENTS / FORMULATION

CONTRACT SERVICES

BIOPHARACEUTICALS

FINISHED DOSAGE

GENERIC APIS

NATURAL EXTRACTS

14 15

FACTS & FIGURES

87%

59%

81%

96%

95%

86%

82%

87% of respondents made new business contracts during

CPhI & P-MEC India 2014

81% of the respondents agreed CPhI & P-MEC India

drives growth and innovation in the pharmaceutical industry

59% of respondentshad more than 6

meetings over 3 days

86% of therespondents met

new existing contacts

96.3% of respondents had more then 1 meeting at

CPhI & P-MEC India 2014

82% of the respondents met with companies considering doing business with during

CPhI & P-MEC India

95% of the respondents agreed that CPhI & P-MEC India is very important event in the

pharmaceutical industry calendar

FACTS & FIGURES

P-MEC Exhibitor by Country

CPhI Exhibitor by Country

IndiaGermanyChina ItalyUSASwitzerland United Kingdom South Korea Spain Belgium France Japan Austria Canada

USA

United Kingdom

India

France

Germany

Italy

Belgium

Switzerland

Japan

ChinaSouth Korea

Spain

Austria

Canada

IndiaChinaUSA GermanyJapanFrance United KingdomIsraelItalySwitzerlandThe Netherlands

USA

United Kingdom

India

France

Germany

Italy

The Netherlands

Switzerland

Israel

Japan

China

16 17’’’’’’’’’’’’’’

’’ ’’’’’’

FETTE Compacting is growing in India and this show has helped us in achieving this. We have launched our best of the tablets machines series here and we are happy that many Indian visitors have shown their interest.Sandeep SoodChief Operating Officer | FETTE Compacting GmbH

I have been visiting CPhI & PMEC India since years and I have seen a growth year on year. This show is the largest and number one in Pharma sector in India and it is very well organized.

Ravin PandeSenior Vice President | Alembic Pharma (Gujarat)

CPhI is a meeting place and it brings in anybody and everybody who is a player in the pharmaceutical space. This is the only show of its kind in India and it’s very important to be familiar with new developments, new expectation of customers and be in touch with the principle companies. Harish ShahManaging Director | Signet Chemical Corporation

This event is so helpful and its very informative. We have visited this event especially for API’s and we have found many new molecules, new products & technologies which we can now work on and also have collected few high-quality leads for our business. Sabita MaharjanSenior Product Development Officer | Omnica Laboratories Pvt. Ltd. (Nepal)

CPhI & PMEC India is a right platform to make our new products available for the all in the Pharma sector. It is because of this show, everyone is aware about our products & offerings that have helped our company in receiving quality leads. Ram Deshpande Director | Sanner GmbH

Every year we see that the show is expanding and its getting more & more organized. We have achieved our business objective and hence our visit to CPhI & PMEC India has been effective Ajay Prabhu Managing Director | Symbiotica Speciality Ingredients (Malaysia)

CPhI India is a platform perfect to launch our new products & technologies focusing on the Indian market. But here at CPhI India we meet Indian visitors as well as the International Visitors.

Kevin MehringPresident, CEO | UAS Laboratories

CPhI & PMEC India is the only place to meet, interact and do business. Everybody from the pharma sector including Bulk Drugs, Packaging, Analytical, engineering looks forward for this event.

Hemadri Mittadoddi Director | Pack World

We have received a lot of customers from India and also from emerging regions like South-East Asia, Middle East, Africa etc. The visitors at CPhI & PMEC India are quality visitors and are focused on what products we offer.

Navin LakhanpaulVice President Sales & Marketing | GEA Pharma Systems

This year at CPhI India, we have received new business leads and this platform gives an opportunity to network and grow with local, domestic clients and also as well as with the international clients like Singapore, Sri Lanka, Egypt, Syria etc.

Anil ToliaPresident | Vidhi Bulk Drugs (Gujarat)

When we visit CPhI India, we find most of our customers and clients are already here at CPhI and this helps us a lot to promote our products in line. This is the largest show in India and hence it is very important for us to be a part of it.

Hugo Dahlstrom International Sales Manager | Merck Millipore (Sweden)

EXHIBITOR TESTIMONIALS VISITOR TESTIMONIALS

18 19

GLIMPSES GLIMPSES

20 21

Indian Express

Prahaar

Shivneri

Yashobhoomi

Aapla Mahanagar

Aapla Mahanagar

ONLINE MEDIA COVERAGEPRINT MEDIA COVERAGE

22 23

Social Media

CPhI & PMEC India conducted an onsite twitter campaign during all three show days. Attendees competed to post the maximum number of tweets in order to win the grand prize – an Apple iPad Mini. This campaign has been very effective and attracted around 100+ exhibitors and 180+ visitors who tweeted and shared their views, CPhI pic-tures, selfies, and exhibitor interactions, etc. on Twitter.

India Pharma Awards 2014

In a glittering ceremony, the Pharma fraternity recognized the talent and performances among its peers at the India Pharma Awards 2014.

UBM India unveiled the winners of the second edition of India Pharma Awards at a Gala Dinner in Mumbai. These awards honoured the innovation and excellence in India’s pharmaceutical industry. Winners were declared across nine categories with over 100 companies participating at the award show.

The India Pharma Awards is the country’s premier industry platform that celebrates the contributions of its key players amongst their Indian and international fraternity. The ceremony was preceded by a panel discussion, titled: FROM VOLUMES TO VALUE PLAY: TOWARDS ACHIEVINGVISION2020’.WherepanelistsdeliberatedonthefactorsholdingbacktheIndianpharma industry and gave their recommended strategies for its success.

183 people tweeted 612

times about CPhI & P-MEC

India 2014 reaching a potential

68,559 people.

FREE MARKETING

Twitter Competition

Twitter Wall

Mobile App

The CPhI & P-MEC mobile app is available for all mobile devices with an internet connection. The apps helps users access the complete exhibitor list, navigate the floor plans, connect with social media updates, check-in the Technical Seminars sessions, meetings, and expand their professional Pharma network.A total of 1,13,796 in-app actions took place from the active users.

Top Tweets from a CPhI India exhibitor: Owen Mumford Top Tweets from a PMEC India exhibitors: Gansons Ltd.

Sponsored by

14,000 attendees downloaded and used the mobile app

during the 2014 show.

NETWORKING & LEARNING

Technical Seminar

Technical Seminars are a yearly recurring feature of the show. These information-packed sessions inform visitors of the latest trends and innovations in the pharma industry.Exhibitor presentations are the fast way to understand the offerings of an exhibiting company. The sessions inform you about the latest products and services the exhibitor has to offer.

1-3 December 2015Bombay Convention & Exhibition Centre,Mumbai, India

Mix with the world of pharma, products, people & solutions

If it’s for Pharma,it’s at CPhI & P-MEC India 2015.

www.cphi.com/india +91 22 6172 7000

C

M

Y

CM

MY

CY

CMY

K

A4_2015Ad.pdf 1 20-01-2015 16:05:23